Pui-hui Wang - Infectious Diseases

Author Information

Pui-hui Wang is affiliated with the State Key Laboratory for Emerging Infectious Diseases, Department of Microbiology, and the Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases at The University of Hong Kong, located in Hong Kong SAR, China. Their work primarily centers around infectious diseases, with a strong emphasis on research related to SARS-CoV-2 and influenza viruses.

Research Contributions

Pui-hui Wang has made significant research contributions in the field of infectious diseases, particularly focusing on SARS-CoV-2 and influenza viruses. Their recent work includes studies on nasal prevention of SARS-CoV-2, development of intranasal vaccines, and investigation of broadly neutralizing antibodies against COVID-19 variants. The research also explores the mechanisms of virus replication and transmission, with notable studies on attenuated virus strains and the efficiency of transmission of different SARS-CoV-2 variants in animal models.

Aliases

Pui-hui Wang is also known by the alias "Pui Wang."

Publication and Citation Metrics

Metric	Value
Total Papers	65
Total Citations	2963
H-index	22

Publications:

Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models

DOI: 10.1016/j.ebiom.2021.103762

Year: 2022

Intranasal administration of a single dose of a candidate live attenuated vaccine derived from an NSP16-deficient SARS-CoV-2 strain confers sterilizing immunity in animals

DOI: 10.1038/s41423-022-00855-4

Year: 2022

An elite broadly neutralizing antibody protects SARS-CoV-2 Omicron variant challenge

DOI: 10.1101/2022.01.05.475037

Year: 2022

Cellular 59-39mRNA Exoribonuclease XRN1 Inhibits Interferon Beta Activation and Facilitates Influenza A Virus Replication

DOI:

Year: 2021

A live attenuated influenza virus-vectored intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2 infection

DOI: 10.1101/2021.11.13.468472

Year: 2021

Low dose inocula of SARS-CoV-2 Alpha variant transmits more efficiently than earlier variants in hamsters

DOI: 10.1038/s42003-021-02640-x

Year: 2021

Mammalian cells use the autophagy process to restrict avian influenza virus replication.

DOI: 10.1016/j.celrep.2021.109213

Year: 2021

Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein

DOI: 10.1038/s41467-021-23166-0

Year: 2021

Cellular 5′-3′ mRNA Exoribonuclease XRN1 Inhibits Interferon Beta Activation and Facilitates Influenza A Virus Replication

DOI: 10.1128/mBio.00945-21

Year: 2021

Low dose inocula of SARS-CoV-2 B.1.1.7 variant initiate more robust infections in the upper respiratory tract of hamsters than earlier D614G variants

DOI: 10.1101/2021.04.19.440414

Year: 2021

Are There Any Recent Developments in Yellow Fever Research?

Which Diseases Are Transmitted by Aedes Aegypti?

What are the Risk Factors for E. Coli Infection?

Why is the Apicoplast Important in Infectious Diseases?

What are the best practices for insect bite prevention?

What Role Does Sanitization Play in Infection Control?

What Are the Challenges in Targeting Fatty Acid Biosynthesis?

Where is Zika Virus Found?

What are Some Examples of Protein Targets in Pathogens?

What Can Be Done to Mitigate These Effects?

Partnered Content Networks

Relevant Topics